In a session on Case Law Updates at the the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting, Chad Shear led a panel discussion with John Dragseth and Dr. John Garvish through a discussion of Bilski and how we got to Bilski.  The case, involved a patent application seeking exclusive rights to a […]

Editor-in-Chief Barista, Stephen Jenei, will be live-blogging the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting on Oct. 20-22, 2008, at the Hard Rock Hotel at Universal Orlando, Orlando, Florida. The Conference should be an excellent opportunity for BIO members to hear, listen, and learn about current and projected topics related to biotechnology […]

There has been a lot of activity at the Supreme Court and at the PTO in the last year. The increase in litigation increases the cost of pursuing patents and the serious pitfalls companies will face if they are not careful. It doesn’t take the Amazing Kreskin to realize that the PTO is rejecting a […]

With billions of dollars at stake as global business practices are scrutinized in the United States, the EU, and Asia, the challenges and consequences could not be greater for high-tech companies. The competition issues raised require detailed analysis of fast-moving areas of technology, such as the Internet, computer software and hardware, platform competition and technology […]

Whether you are a company conducting diligence or a target being examined, you need to ensure the value of the IP with a thorough and effective IP due diligence review. In this light, the American Conference Institute’s 6th National Conference on Pharma/Biotech IP Due Diligence will be held at the Marriott East Side, New York, […]

BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference entitled Pharmaceutical Patent Law: A Prescription for Success in Challenging Times. The conference will be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington, VA, on November 12, 2008. BNA offers a prescription for success as legislative, judicial, administrative, […]

BIO’s Intellectual Property Counsel Committee is holding its Fall Conference and Committee Meeting on Oct. 20-22, 2008, at the Hard Rock Hotel at Universal Orlando, Orlando, Florida. BIO’s semi-annual IP Counsels’ Committee Conference is an excellent opportunity for BIO members to hear, listen, and learn about current and projected topics related to biotechnology IP. In […]

Jon Dudas, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office has (proudly?) highlighted the fact that the allowance rate for patents is currently 42%.  This is in contrast to allowance rates in excess of 70% just eight years ago.  So, did patent applications really get that […]